Bone density studies in pregnant women receiving heparin

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 65, Issue 2, 1996, Pages 171-174

  Shefras, Julia ^a   Farquharson, Roy G ^a  

^a LIVERPOOL WOMEN S HOSPITAL   (United Kingdom)

Author keywords

Bone density; Heparin; Pregnancy

Indexed keywords

DALTEPARIN; HEPARIN; PHOSPHOLIPID ANTIBODY;

ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BONE ATROPHY; BONE DENSITY; BREAST FEEDING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FETUS; HUMAN; LUMBAR SPINE; PREGNANCY; PRIORITY JOURNAL;

EID: 0029930539     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/0301-2115(95)02358-5     Document Type: Article

References (18)

1. Cowchock S, Reece E, Balaban D, Branch D, Plouffe L. Repeated fetal losses associated with anti-phospholipid antibodies: A collaborative randomised trial comparing prednisolone with low dose heparin treatment. Am J Obstet Gynaecol 1992; 166: 1318-1323.
2. Branch DW, Silver R, Blackwell J, Reading J, Scott J. Outcome of treated pregnancies in women with anti-phospholipid syndrome: An update of the Utah experience. Obstet Gynaecol 1992; 80: 614-620.
3. Farquharson R, Bloom A, Compston A. The Lupus anti-coagulant: A place for pregnancy treatment? Lancet 1985: 2: 842-843.
4. Griffiths H, Liu D. Severe heparin osteoporosis in pregnancy. Postgrad Med J 1984: 60: 424-425.
5. Zimran A, Shilo S, Fisher D, Bab I. Histomorphometric evaluation of reversible heparin-induced osteoporosis in pregnancy. Arch Intern Med 1986; 146: 386-388.
6. Dahlman T. Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the pueperium in 184 women undergoing thromboprophylaxis with heparin. Br J Obstet Gynaecol 1993; 168: 1265-1270.
7. Matzsch T, Bergquist D, Hedner Ulla, Nilsson B, Ostergaard P. Effects of low molecular weight heparin and unfragmented heparin on induction of osteoporosis in rats. Thromb Haemost 1990; 63: 505-509.
8. Monreal M, Vinas L, Monreal L, Lavin S, Lafoz E, Angles A. Heparin-related osteoporosis in rats: A comparative study between unfractionated heparin and low molecular weight heparin. Haemostasis 1990; 20: 204-207.
9. Quenby S, Farquharson R. Predicting recurrent miscarriage -What is important? Obstet Gynaecol 1993; 82: 132-138.
10. Malia R, Topping J, Cooper S, Greaves M, Farquharson R. The anti-coagulant efficacy of low molecular weight heparin (Fragmin) in patients with APA-associated recurrent pregnancy loss. Lupus 1994; 3: 318 (abstract).
11. Laskey M, Flaxman M, Barber R, Trafford S, Hayball M, Lyttle K, Crisp A, Compston J. Comparative performance in vitro and in vivo of Lunar DPX and Hologic QDR 1000 dual energy X-ray absorptiometry. Br J Radiol 1991; 64: 1023-1029.
12. National Radiation Protection Board. Documents of the NRPB 1993; 14: 10-11.
13. Lamke B, Brundin J, Moberg P. Changes in bone mineral content during pregnancy and lactation. Acta Obstet Gynecol Scand 1977; 56: 217-219.
14. Christiansen C, Rodbro P, Heinild B. Unchanged total body calcium in normal human pregnancy. Acta Obstet Gynaecol Scand 1976; 55: 141-143.
15. Sowers M, Crutchfield M, Jaunausch S, Updike S, Corton G. A prospective evaluation of bone mineral change in pregnancy. Obstet Gynaecol 1991; 77: 841-845.
16. Dahlman T, Sjoberg H, Hellgren M. Calcium homeostatis in pregnancy during long-term heparin treatment. Br J Obstet Gynaecol 1992; 99: 412-416.
17. Dahlman C, Sjoberg H, Ringertz H. Bone mineral density during long-term prophylaxis with heparin in pregnancy. Am J Obstet Gynaecol 1994; 170: 1315-1320.
18. Barbour LA, Steven DK, Steiner JF, LoVerde ME, Heddleston LN, Lear JL, Baron AE, Barton PL. A prospective study of heparin-induced osteoporosis in pregnancy using bone densitometry. Am J Obstet Gynecol 1994; 170: 862-869.